Dual Biomarker Assays Market By Product Type (Immunochemistry Assay, In-situ Hybridization (ISH) Assay, Next-Generation Sequencing (NGS) Kits, and Others), By Application (Cancer, Non-Small Cell Lung Cancer (NSCLC), Human Papillomavirus (HPV), Glioma, Gastrointestinal Cancer, Breast Cancer, B-Cell Lymphoma, and Alzheimer’s Disease), By End-user (Hospitals, Specialty Clinics, Diagnostic Laboratories, and Cancer Research Institutes), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
Report Overview The Dual Biomarker Assays Market Size is expected to be worth around US$ 2.7 billion by 2034 from US$ 0.9 billion in 2024, growing at a CAGR of 11.6% during the forec...